Cancer Types | Sarcoma - National Foundation for Cancer Research

Sarcoma

Sarcomas are cancers that start in bones, muscles, connective tissues, blood vessels or fat, and can be found anywhere in the body. There are more than 50 different types of sarcoma, which fall into two main categories: bone cancers and soft tissue cancers.

Key Facts

  • An estimated 13,400 new cases of soft tissue sarcomas and 3,970 new cases of bone cancers will be diagnosed in the U.S. in 2023, with around 7,280 deaths expected to result from the diagnosis.
  • Sarcomas are rare in adults and make up approximately 1% of all adult cancer diagnoses.
  • Sarcomas are relatively more common among children. Between 1,500 and 1,700 children are diagnosed with a bone or soft tissue sarcoma in the U.S. each year. This makes up about 15% of cancers in children under the age of 20.
  • The overall relative five-year survival rate for people with soft tissue sarcoma is around 65% and for people with bone cancer, the overall relative five-year survival rate is 70%. The rate differs depending on the type of bone cancer.
  • When the sarcoma starts in an arm or leg, the five-year survival rates are slightly higher for each stage when compared with sarcoma that starts in other locations.
Source: American Cancer Society’s Cancer Facts & Figures 2023; Sarcoma Alliance; and American Society of Clinical Oncology’s Cancer.Net

Signs and Symptoms

A symptom is a change in the body that a person can see and/or feel. A sign is a change that the doctor sees during an examination or on a laboratory test result. If you have any of the symptoms below, it does not mean you have cancer but you should see your doctor or health care professional so that the cause can be found and treated, if needed.

Soft Tissue Sarcoma

  • A lump that is increasing in size or becomes painful
  • A lump of any size that is located deep within a muscle
  • Abdominal pain that’s getting worse
  • Blood in your stool or vomit
  • Black, tarry stools

Bone Cancer

  • Bone pain that becomes constant over time and worsens with activity.
  • Swelling near pain area that happens later; may feel lump depending on location
  • Neck bone cancers may cause a lump in the throat; Difficulty to swallow or breathe.
  • Bone cancer most of time does not fracture; Feeling sudden bone pain after soreness for months may indicate fracture.
  • Cancer in spine bones can press on nerves, causing numbness, tingling or weakness.
Source: American Cancer Society and Sarcoma Alliance 2023
Sarcoma Cancer Location
17370
new cases of sarcoma expected in 2023
7230
deaths expected in 2023
65
% 5-year survival rate for soft tissue sarcoma
Yellow Sarcoma Ribbon

Sarcoma Cancer Awareness Month is recognized in July. To help accelerate cures please make a gift today.

Researchers Working on Sarcoma Cancer

Cesare Spadoni, Ph.D.
University of London
Wei Zhang, Ph.D.
Wake Forest Baptist Medical Center

Related Content

Bone Cancer 101

July is Bone Cancer Awareness Month. Bone cancer is a rare form of cancer, often overlooked by most Americans, but affects thousands of Americans annually. There are two primary types of bone cancer: 1) primary bone cancer, which originates in the bone tissue and can be either cancerous (malignant) or non-cancerous (benign); and 2) metastatic tumors of the bone tissue (which originated elsewhere in the body and then metastasized, or spread, to the bone). Whereas primary bone cancer is exceedingly rare, accounting for only 3,450 new cases each year--less than 1% of all cancers--more than an estimated 280,000 adults are living with metastatic cancer, which has spread to their bones.   Types of Primary Bone Cancer and Survival Rates Primary bone cancers are defined and categorized by the cells within the bone that initially gave rise to cancer. The most common types are Osteosarcoma, Chondrosarcoma, Ewing sarcoma, and Chordoma.  Osteosarcoma develops from bone-forming cells called osteoblasts in osteoid tissue (immature bone tissue). In children, it typically forms near the shoulder or knee. But in adults, can form in any bones, and is more common in non-white ethnic groups.  Chondrosarcoma develops from cartilage tissue, usually of the pelvis, upper leg, or shoulder. It is most common in adults above the age of 40.    Ewing sarcoma is a cancer of the bone and soft tissue. It is common in children and adolescents under 19 years old. While it can form in any bone, it is most common in the pelvis, legs, and ribs.   Chordoma is a very rare cancer that forms in the spine.   The survival rates for bone cancer vary significantly by type. For Osteosarcoma, localized cases have a survival rate of 74%. While distant cases (widespread metastasis) have a rate of 27%. For Ewing Tumors, localized cases have a survival rate of 81%, while distant cases have a rate of 38%. Chondrosarcoma has a localized survival rate of 91%, the highest, and a distant survival rate of 22%. Chordoma has a localized survival rate of 87% and the highest distant survival rate, at 55%. Bone Cancer Symptoms The symptoms of bone cancer also vary. The most common symptom experienced by most patients is pain in the affected bone. At first, the pain is usually intermittent but becomes more constant as the cancer progresses. Other symptoms may include swelling in the area of the cancer, lumps near the cancer, and fractures due to weakening of the bone. Systemic symptoms can include weight loss and fatigue. Risk Factors Some common risk factors include: Genetics – some bone cancers, especially Osteosarcomas and Chordomas, are hereditary or caused by mutations. Radiation – exposing bones to ionizing radiation increasing their risk of developing bone cancer. Multiple exostoses - a syndrome that causes bumps on a person’s bones, can be a cause of some Chondrosarcomas. Enchondromas - benign cartilage tumors, are linked to an increased risk of Chondrosarcomas. Tuberous sclerosis - an inherited condition caused by mutations, is linked to early childhood Chordomas. Paget Disease - can increase one’s risk of bone cancers, especially Osteosarcoma. Treatment Options The typical forms of treatment for bone cancers include surgery, therapy using a medication, radiation therapy, or some combination of the three. Therapeutic medications may include chemotherapy, targeted therapy, or immunotherapy. Immunotherapies are generally not [...]

Sarcoma: The Young Person’s Cancer?

Sarcoma is quite a rare diagnosis in adults. This specific type of cancer makes up less than 1% of adult cancer diagnoses. Surprisingly, it is relatively more common among children. Most cancers have a name that paints an image. If someone has liver cancer, the mind quickly pictures the upper right region of the abdomen. When hearing of brain cancer, it’s easy to know that the tumor lies somewhere within the skull. Sarcoma, however, is a cancer that remains a mystery no matter how many times one may hear the name. This particular type of cancer begins in connective tissues, such as bones, muscles, or fat cells. Connective tissues can be found throughout the human body, meaning it is possible for sarcoma to occur in any area of one’s body. What makes this cancer even more peculiar, however, is the age group in which it develops most frequently. Unlike most types of cancers, sarcoma is most commonly found in children and young adults. With the first of July marking the official start of National Sarcoma Awareness Month, there is no better time to unveil the mysteries of this unique disease. Types of Sarcoma Though there are many types of connective tissue that can be affected by sarcoma, there are two main types that encompass the majority of cancer cases. The first type is soft-tissue sarcoma, which starts in muscles, fat, blood vessels, or other tissues within the body. It is possible for soft-tissue sarcoma to occur in any body part, though it typically begins in the arms or the legs. Symptoms often include lumps, swelling, and bowel problems. The second type is bone sarcoma. Bone sarcoma can begin in a variety of locations, including near the ends of leg and arm bones, pelvic bones, ribs, shoulder blades, or even the middle of a leg bone. Though bone sarcoma isn’t limited to one region, the symptoms are quite specific. People experiencing bone pain, especially if it worsens at night or with activity, should speak to their doctor immediately. Bone sarcoma can also result in swelling around the area of the bone affected. Who’s at risk? Age is the biggest single risk factor for cancer. In general, the risk of developing cancer greatly increases after the age of 50 and half of all cancers occur from the age 66 on. Sarcoma, however, is quite a rare diagnosis in adults. This specific type of cancer makes up less than 1% of adult cancer diagnoses. Surprisingly, it is relatively more common among children. Each year, between 1,500 and 1,700 children in the United States are diagnosed with bone or soft-tissue sarcoma, meaning sarcoma makes up about 15% of cancers in children under the age of 20. NFCR supported researcher Dr. Cesare Spadoni is leading a team to develop treatments for rhabdomyosarcoma, the most common pediatric soft tissue sarcoma. Spadoni’s team is using the small molecule drug, Volasertib. With support from the NFCR AIM-HI Translational Research Initiative, Volasertib has advanced in pre-clinical research toward clinical trials. A Phase I clinical trial will begin in 2020. A common misconception of cancer in young adults is that [...]

Sarcoma Origin Identified

Cancer is anything but a straightforward disease; one tumor type can be entirely different from another not only in location, but causal agent and origin. There is differentiation even within the same type of cancer. Take sarcoma, which is in fact an umbrella term for nearly 100 cancers originating in the skeleton or the soft parts of the body. Some affect the young, others the elderly. But now a study out of Sweden is bringing the starting points of some sarcomas into focus by identifying for the first time an interaction between specific proteins. “We now know which mechanisms to shine the spotlight on,” says Pierre Åman, Professor of Tumor Biology at Sahlgrenska Academy, University of Gothenburg, the corresponding author behind an article published in the journal EMBO Reports. Osteosarcomas develop in bone; liposarcomas form in fat; rhabdomyosarcomas form in muscle; Ewing sarcomas form in bone and soft tissue, and Kaposi’s sarcoma is practically synonymous with HIV/AIDS infection. However, among cancers, sarcoma is relatively uncommon; in the United States, around 12,750 people — 7,240 men and boys and 5,510 women and girls  — will be diagnosed with a soft-tissue sarcoma (STS) this year. The overall five-year survival rate for people with STS is around 65 percent; if the cancer is caught early and has not left its point of origin, the survival rate can be as high as 81 percent; if the sarcoma has spread to another area of the body, the 5-year survival rate falls precipitously to 16 percent. However, rates vary based on the specific type and the stage, or extent, of the sarcoma, showing how even just one type of cancer can have wildly different subsets. In the Swedish study, the 15 or more different forms of sarcoma studied were found to be caused by mutations in the FET family of proteins, involved in the regulation of lifespan and stress resistance, acting partially through the insulin/IGF-signaling pathway. The new results show that most of the tumor-altered FET proteins bind to another protein complex, SWI/SNF, which regulates gene activity, cell maturity and growth. This interaction results in SWI/SNF misregulation and, accordingly, disruptions in the genetic programming within a cell. The misregulation is a mechanism common to all the 15 or more forms of tumor caused by mutations in the FET genes. This now gives oncologists a solid target upon which to aim their efforts, and could clear the way for some type of screening technology. Importantly, the FET family is already a focus of scientific inquiry: they are of medical interest because chromosomal rearrangements of their genes promote not only various sarcomas, but because point mutations in FUS or TAF15 (both FET) can cause neurodegenerative diseases such as amyotrophic lateral sclerosis and frontotemporal lobar dementia. Because of that, “There are already an abundance of new drug candidates that affect this protein complex and are being tested on other diseases,” Åman says. “With the discoveries we’ve now made, we can test the same candidates on these forms of sarcoma as well.” July is Sarcoma Awareness Month, and studies such as Åman’s continue to shed light on the cancer’s ultimate […]